The current pandemic due to widespread SARS-CoV-19 infection has again highlighted the
role of obesity, whose global prevalence increased up to 13%, as a risk factor for both …

Background The aim of this study was to estimate the prevalence of pneumonia and
secondary bacterial infections during the pandemic of influenza A (H1N1) pdm09. Methods …

Objective The aim of this study was to further clarify clinical characteristics and predict
mortality risk among patients with viral pneumonia. Methods A total of 528 patients with viral …

With the increasing prevalence of obesity, there is a growing awareness of its impact on
infectious diseases. In past epidemics of influenza A and Middle East respiratory syndrome …

To the Editor—The COVID-19 pandemic, caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is a public health problem of historic dimensions. However …

Background Neuraminidase inhibitors were widely used during the 2009–10 influenza A
H1N1 pandemic, but evidence for their effectiveness in reducing mortality is uncertain. We …

The interactions between obesity and infectious diseases have recently received increasing
recognition as emerging data have indicated an association between obesity and poor …

Since December 2019, COVID-19 has aroused global attention. Studies show the link
between obesity and severe outcome of influenza and COVID-19. Thus, we aimed to …

Background: Systematic reviews of randomized, controlled trials in patients with influenza
suggest a lack of evidence about the effects of antiviral therapy on several patient-important …

Background It is unclear whether an 'obesity survival paradox'exists for pneumonia.
Therefore, we conducted a meta-analysis to assess the associations between increased …